APA (7th ed.) Citation

E, M., G, T., M, F., A, P., L, J. M., A, C., . . . SAM, U. (2024). Formulation and clinical evaluation of carbidopa/levodopa oral solution for the treatment of sepiapterin reductase deficiency. European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, 203, 114429. https://doi.org/10.1016/j.ejpb.2024.114429

Chicago Style (17th ed.) Citation

E, Maines, et al. "Formulation and Clinical Evaluation of Carbidopa/levodopa Oral Solution for the Treatment of Sepiapterin Reductase Deficiency." European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V 203 (2024): 114429. https://doi.org/10.1016/j.ejpb.2024.114429.

MLA (9th ed.) Citation

E, Maines, et al. "Formulation and Clinical Evaluation of Carbidopa/levodopa Oral Solution for the Treatment of Sepiapterin Reductase Deficiency." European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V, vol. 203, 2024, p. 114429, https://doi.org/10.1016/j.ejpb.2024.114429.